Ocular Therapeutix (OCUL) Tops Q3 EPS by 11c
Tweet
Share
E-mailGet Alerts OCUL Hot Sheet
Join SI Premium – FREE
Ocular Therapeutix (NASDAQ: OCUL) reported Q3 EPS of ($0.39), $0.11 better than the analyst estimate of ($0.50). Revenue for the quarter came in at $477 thousand versus the consensus estimate of $470 thousand.
For earnings history and earnings-related data on Ocular Therapeutix (OCUL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ocular Therapeutix (OCUL) PT Raised to $25 at H.C. Wainwright
- Deutsche Bank Starts DexCom (DXCM) at Buy
- Deutsche Bank Starts Tandem Diabetes Care (TNDM) at Hold
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
